Pharmaceutical composition comprising a ryanodine receptor antagonist for facilitating wound healing
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 12, 2017
Grant Date -
Oct 20, 2016
app pub date -
Dec 12, 2014
filing date -
Dec 12, 2013
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention relates to the use of pharmaceutical compositions containing as the active agent a compound of formula I in the treatment of dermal wounds. The compositions may be used for the promotion of healing of wounds affecting the deeper layers under the epithelium, including dermal- and sub dermal connective tissue, being cut, punctured, sliced wounds or originating in insufficient tissue perfusion, chronic diseases or other harms. The compositions are formulated for local application and may comprise other active agents contributing to wound healing in addition to a compound of formula (I).
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully